Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1993
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance
J K Actor, M Shirai, M C Kullberg, et al.
Virology
|
April 1, 1992
Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo
T N Fredrickson, J M Sechler, G J Palumbo, et al.
The EMBO Journal
|
July 19, 2000
Potential role of PKR in double-stranded RNA-induced macrophage activation
L B Maggi, M R Heitmeier, D Scheuner, et al.
European Journal of Immunology
|
December 1, 1994
Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation
J K Actor, M A Marshall, I A Eltoum, et al.
Virology
|
August 11, 2000
Selective inhibition of nuclear steroid receptor function by a protein from a human tumorigenic poxvirus
N Chen, T Baudino, P N MacDonald, et al.
Cell
|
October 2, 1992
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein
M K Spriggs, D E Hruby, C R Maliszewski, et al.
The Journal of Experimental Medicine
|
August 1, 1988
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)
R A Yetter, R M Buller, J S Lee, et al.
The Cancer Journal From Scientific American
|
January 1, 1996
In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta
G R Peplinski, A K Tsung, M J Casey, et al.
Vaccine
|
October 11, 2011
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus
Karen L Denzler, Jill Schriewer, Scott Parker, et al.
Vaccine
|
December 1, 1988
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus
R A Olmsted, R M Buller, P L Collins, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1993
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance
J K Actor, M Shirai, M C Kullberg, et al.
Virology
|
April 1, 1992
Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo
T N Fredrickson, J M Sechler, G J Palumbo, et al.
The EMBO Journal
|
July 19, 2000
Potential role of PKR in double-stranded RNA-induced macrophage activation
L B Maggi, M R Heitmeier, D Scheuner, et al.
European Journal of Immunology
|
December 1, 1994
Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation
J K Actor, M A Marshall, I A Eltoum, et al.
Virology
|
August 11, 2000
Selective inhibition of nuclear steroid receptor function by a protein from a human tumorigenic poxvirus
N Chen, T Baudino, P N MacDonald, et al.
Cell
|
October 2, 1992
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein
M K Spriggs, D E Hruby, C R Maliszewski, et al.
The Journal of Experimental Medicine
|
August 1, 1988
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS)
R A Yetter, R M Buller, J S Lee, et al.
The Cancer Journal From Scientific American
|
January 1, 1996
In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta
G R Peplinski, A K Tsung, M J Casey, et al.
Vaccine
|
October 11, 2011
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus
Karen L Denzler, Jill Schriewer, Scott Parker, et al.
Vaccine
|
December 1, 1988
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus
R A Olmsted, R M Buller, P L Collins, et al.
Page
of 6